CClinicalTrials.gg
CompletedNCT01223300Updated Dec 19, 2016

Osteoporosis Research Registry

An observational study in Osteoporosis, sponsored by Northwestern University. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2016-12-19.

Sponsored by Northwestern University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
12
Sex
All
01

Study summary

The aim of this research registry is to collect information on individuals with osteoporosis, those with risk factors for osteoporosis, and comparative healthy controls. Bone mineral density measurements will be done on these individuals to determine bone health.

Read the detailed description

The goal of this project is to develop a registry of research subjects with OP, with a risk of developing OP, and healthy controls. DXA scans will be performed on willing individuals at the spine, hips, and forearms and possibly the legs and heels in order to determine BMD. Subjects will also be asked to provide two (10 ml) blood samples, which may be used to analyze Vitamin D levels and/or other bone markers. By participating in the registry, subjects will be considered for current and future clinical research studies.

02

Conditions studied

  • Osteoporosis

Browse trials for

03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's enrollment of 12 is below the median of 174 across 446 observational studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals with osteoporosis or at risk for osteoporosis. Also, healthy controls.

Inclusion criteria

  • Any subjects who give written informed consent

Exclusion criteria

Exclusion Criteria:

  • Any individual who is not willing or able to give written informed consent
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
12 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Osteoporosis
06

What researchers measure

Primary outcomes

  1. BMD

    Time frame: 0 months

Secondary outcomes

  1. Bone markers

    Time frame: 0 months

07

Study locations

1 site
  • Northwestern University Feinberg School of Medicine
    Chicago, Illinois 60611, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01223300
Lead sponsor
Northwestern University
Collaborators
Shirley Ryan AbilityLab
Responsible party
Thomas J. Schnitzer (professor, Northwestern University) — Principal investigator
First posted
Oct 18, 2010
Start date
Nov 2008
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Dec 19, 2016

Study contacts

Thomas J Schnizter, M.D., PhD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion